Skip to main content
OpenTrials

Clinical trial condition

Acellular Pertussis

Explore clinical trials studying Acellular Pertussis. Study availability and eligibility vary by location and protocol.

64 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Acellular Pertussis trial results

Completed

Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years

NCT00346073

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
View all 42 locations
View Trial Details
Completed

Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine

NCT00635128

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
Locations
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Oberkirch, Baden-Wurttemberg, Germany
  • GSK Investigational Site Offenburg, Baden-Wurttemberg, Germany
View all 38 locations
View Trial Details
Completed

Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

NCT01323959

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site Derval, France
  • GSK Investigational Site La Chapelle-Basse-Mer, France
  • GSK Investigational Site La Riche, France
  • GSK Investigational Site Nantes, France
View all 15 locations
View Trial Details

Related conditions